The Incubation Shaker Advancing mRNA Vaccine Development

By Melissa Chen Montes de Oca

mRNA technology is driving forward innovative vaccines and therapeutics by taking a different approach in how they interact with immune systems. Traditional vaccines often involve introducing weakened or inactivated pathogens to stimulate an immune response, while mRNA vaccines deliver a small piece of synthetic mRNA that encodes a viral protein. This mRNA method was used in the development of COVID-19 vaccines and has since been explored in relation to the field of cancer therapies.

Alongside the great promise of mRNA vaccine development, comes a list of unique challenges to overcome. Researchers are tackling these challenges while striving for a shorter time to market that will patients.